Geoffrey Hill, MD, FRACP, FRCPA

Geoffrey  Hill, MD, FRACP, FRCPA

Geoffrey Hill, MD, FRACP, FRCPA

  • Physician, Fred Hutch
  • Senior Vice President and Director, Translational Science and Therapeutics Division, Fred Hutch
  • Director of Hematopoietic Stem Cell Transplantation, Fred Hutch
  • Scientific Director, Immunotherapy Integrated Research Center (IIRC), Fred Hutch
  • Professor, Translational Science and Therapeutics, Fred Hutch
  • Professor, Division of Hematology and Oncology, University of Washington School of Medicine


“Seeing patients cured of leukemia and returning to normal life is highly rewarding.”

— Dr. Hill

Why do you conduct research?

Early in my career, I was caring for a man, about the same age as me, who was an up-and-coming musician. His leukemia had relapsed and there were no treatment options left that could cure him. He didn’t want to spend the time he had left in a hospital, so I would meet him at a local park or his home to provide palliative care, easing his symptoms and making him comfortable. Although I couldn’t save his life, he made a deep impression on mine: I realized that doing research was the best way to save the lives of people like him. Seeing patients with poor outcomes after transplants drives me to keep searching for answers.

What do you want patients to know about working with you?

In my clinical practice, I see a lot of patients with complications following bone marrow transplants — a curative therapy for otherwise fatal blood cancers — that can be difficult to address. I go into the lab to understand what’s going on biologically so that I can develop new treatments and try to prevent some of these complications. What I do in the lab is constantly informed by my interactions with patients — I’m always striving to improve their outcomes. When working with me, you can expect to have candid discussions about your illness and your treatment options. I want you to be fully informed, understanding the pros and cons of each choice, so that we can make decisions together.

Provider Background

Area of Clinical Practice

Adult blood and marrow transplantation

Blood Cancers

As a hematologist and the director of hematopoietic stem cell transplantation at Fred Hutch, I treat patients with blood cancers like leukemia. I also work closely with experts at Fred Hutch to identify ways to combine transplantation with emerging immunotherapies (therapies that harness the immune system) to fight cancer. My background includes leading the bone marrow transplantation and cancer programs at QIMR Berghofer Medical Research Institute in Brisbane, Australia, and caring for patients at the Royal Brisbane and Women’s Hospital. As a senior principal research fellow of Australia’s National Health and Medical Research Council, I have co-authored more than 150 journal articles on stem cells, transplantation and graft-versus-host disease (GVHD), a potentially life-threatening complication of transplantation.

In the lab, I focus on understanding the immunological mechanisms of GVHD and developing novel therapeutic strategies for prevention and treatment. My research has led to the development of multiple new drugs for GVHD, many of which are currently used in patient care or are undergoing clinical trials.



Education, Experience and Certifications

Medical Degree
University of Auckland Medical School

Rotorua Hospital; Waikato Hospital

Caterbury Health; Dana Farber Cancer Institute

Teaching Appointment, Queensland Institute of Medical Research


All news
Pre-transplant microbiome sets the stage for GVHD Preclinical findings highlight bacterial groups that influence GVHD risk July 21, 2023
New approach could make bone marrow transplantation safer, stronger Tests prevented relapse, limited GVHD in laboratory models of leukemia, multiple myeloma October 14, 2022
Fred Hutch hosts inaugural Dr. E. Donnall Thomas Symposium Event draws leading researchers in transplantation, gene and cell therapy October 7, 2022

Clinical Trials

We make promising new treatments available to you through studies called clinical trials led by Fred Hutch physicians. Many of these trials at Fred Hutch have led to FDA-approved treatments and have improved standards of care globally. Together, you and your physician can decide if a study is right for you.

View Clinical Trials


Many of our Fred Hutch physicians conduct ongoing research to improve standards of patient care. Their work is evaluated by other physicians and selected for publication to the United States National Library of Medicine, the largest medical library in the world. See scientific papers this Fred Hutch physician has written.

View Dr. Hill's Publications

Your Care Team

At Fred Hutch, you receive care from a team of providers with extensive experience in your disease. Your team includes physicians, a patient care coordinator, a registered nurse, an advanced practice provider and others, based on your needs. You also have access to experts like registered dieticians, social workers, acupuncturists, psychiatrists and more who specialize in supporting people with cancer or blood disorders.


Fred Hutch accepts most national private health insurance plans as well as Medicare. We also accept Medicaid for people from Washington, Alaska, Montana and Idaho. We are working to ensure that everyone, no matter what their financial situation, has access to the care they need.

For the Media

The Media Relations team at Fred Hutch is available to assist members of the news media who would like to arrange interviews with providers.

Email or call 206.667.2210